Wikidata

(Q37376588)

English

Is it possible to discontinue imatinib mesylate therapy in Chronic Myeloid Leukemia patients with undetectable BCR/ABL? A case report and a review of the literature

scientific article published on 22 January 2009

In more languages

Statements

title
Is it possible to discontinue imatinib mesylate therapy in Chronic Myeloid Leukemia patients with undetectable BCR/ABL? A case report and a review of the literature (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
19167064
retrieved
20 August 2017
author name string
Salvatore Guastafierro
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
19167064
retrieved
20 August 2017
Umberto Falcone
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
19167064
retrieved
20 August 2017
Maria Celentano
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
19167064
retrieved
20 August 2017
Milena Coppola
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
19167064
retrieved
20 August 2017
Maria Giovanna Ferrara
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
19167064
retrieved
20 August 2017
Antonello Sica
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
19167064
retrieved
20 August 2017
publication date
22 January 2009
1 reference
stated in
Europe PubMed Central
PubMed ID
19167064
retrieved
20 August 2017
page(s)
1079-1081
1 reference
stated in
Europe PubMed Central
PubMed ID
19167064
retrieved
20 August 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q37376588&oldid=1702807209"